Skip to main content
Equibles

SR One Capital Management, LP

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1910264 Redwood City, CA
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$32,143,353
-$80,258 QoQ
Shares Held
4,012,903
0.0% QoQ
Ownership
4.04%
of shares outstanding
% of Portfolio
3.09%
of 13F equity value
Holder Rank
#8
of 209 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SR One Capital Management, LP holds $1,012,394,333 across 14 Biotechnology names. SPRY ranks #10 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MANE
Veradermics, Inc
 2,401,868 $295,285,651
2 ZBIO
Zenas BioPharma, Inc.
 5,037,854 $127,860,734
3 CRSP
CRISPR Therapeutics AG
 2,038,763 $111,194,134
4 AVLN
Avalyn Pharma Inc.
 3,308,649 $108,920,725
5 DSGN
Design Therapeutics, Inc.
 6,526,476 $94,438,107
6 ODTX
Odyssey Therapeutics, Inc.
 3,794,883 $71,002,260
7 ALMS
Alumis Inc.
 1,959,896 $55,151,473
8 ORIC
Oric Pharmaceuticals, Inc.
 4,615,384 $49,984,608

All Filings in SPRY

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,143,353 4,012,903
2026-03-31 $32,223,611 4,012,903
2025-12-31 $46,750,319 4,012,903
2025-09-30 $40,329,675 4,012,903
2025-06-30 $70,025,157 4,012,903
2025-03-31 $50,482,319 4,012,903
2024-12-31 $42,336,126 4,012,903
2024-09-30 $58,187,093 4,012,903
2024-06-30 $34,149,804 4,012,903
2024-03-31 $41,011,868 4,012,903
2023-12-31 $21,990,708 4,012,903
2023-09-30 $15,168,773 4,012,903
2023-06-30 $26,886,450 4,012,903
2023-03-31 $26,123,998 4,012,903
2022-12-31 $25,672,544 3,009,677